Rigel Pharmaceuticals effects 1-for-10 reverse stock split effective June 27, 2024

RIGEL PHARMACEUTICALS INC

Board approved 1-for-10 reverse split on June 15; effective June 27 at 12:01 a.m. ET.
Common stock now trades under new CUSIP 766559702.
No fractional shares issued; cash paid for fractions based on prior-day closing price.
Stockholders authorized a split ratio range of 1:2 to 1:20 at May 24, 2024 annual meeting.
Amendment to certificate of incorporation filed with Delaware Secretary of State.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.